Matthew L. Posard is Director at HALOZYME THERAPEUTICS, INC. (HALO). They have made 6 open-market trades across 4 companies since 2013, most recently 2026-10-01.
CIK 0001543792
3 open-market purchases totalling $2.2M since 2021, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HALO | SELL · 10b5-1 | 2026-10-01 | 2026-10-02 | $108.54 | $568K | +7.0% | — | — |
| HALO | SELL · 10b5-1 | 2026-09-16 | 2026-09-17 | $107.74 | $2.0M | +1.2% | — | — |
| HALO | SELL | 2024-08-12 | 2024-08-14 | $56.82 | $2.3M | +7.0% | +7.2% | +2.6% |
| HALO | SELL | 2024-06-11 | 2024-06-13 | $50.32 | $1.0M | +5.9% | +7.0% | +21.0% |
| HALO | SELL | 2022-12-02 | 2022-12-06 | $56.89 | $1.7M | +1.3% | -3.4% | -19.0% |
| NAUT | BUY | 2021-11-30 | 2021-12-01 | $4.51 | $226K | +15.7% | +12.6% | -15.0% |
| TLIS | BUY | 2021-02-17 | 2021-02-19 | $16.00 | $1.0M | -34.3% | -38.7% | -54.8% |
| DMTK | BUY | 2021-01-11 | 2021-01-13 | $29.50 | $1000K | -4.7% | +82.2% | +4.5% |
| ILMN | SELL · 10b5-1 | 2013-05-30 | 2013-05-30 | $70.80 | $201K | -12.3% | -3.4% | -3.4% |
| ILMN | SELL · 10b5-1 | 2013-04-11 | 2013-04-15 | $57.95 | $2.8M | -12.3% | -3.4% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.